Longevity & AgingChina Launches 2000-Person Stem Cell Trial to Combat Age-Related Decline
China's top military hospital, 301 Hospital in Beijing, has launched the country's first large-scale clinical trial testing whether stem cells can slow age-related physical decline. The trial will enroll 2,000 adults aged 50 and older across multiple centers. The treatment, called amimestrocel (brand name Ruibosheng), uses mesenchymal stem cells from umbilical cord tissue. It was already approved in China in early 2025 for a serious transplant complication, giving researchers a safety foundation to build on. Scientists hope to find out whether stem cells can reduce inflammation and support tissue repair broadly enough to preserve physical function and quality of life as people age — a preventive approach rather than treating diseases one at a time.
